Centers for Disease Control and Prevention (CDC)
1600 Clifton Road
Atlanta
Georgia
30333
United States
Tel: 404-639-3311
Website: http://www.cdc.gov/
Email: netinfo@cdc.gov
780 articles with Centers for Disease Control and Prevention (CDC)
-
Roche joins forces with the U.S. Centers for Disease Control and Prevention to strengthen laboratory systems in the fight against the HIV and tuberculosis epidemics
2/28/2023
Roche announced the expansion of its collaboration with the U.S. Centers for Disease Control and Prevention to strengthen laboratory capabilities in countries greatly affected by the HIV and tuberculosis epidemics.
-
Ginkgo Bioworks and XpresCheck Expand CDC's Traveler-Based Genomic Surveillance Program to Detect Influenza Variants
1/17/2023
Ginkgo Bioworks (NYSE: DNA) and XWELL, Inc. (Nasdaq: XWEL) today announced that they have expanded their support for the Centers for Disease Control and Prevention's (CDC's) Traveler-based Genomic Surveillance program to include a pilot study monitoring influenza viruses in addition to SARS-CoV-2.
-
Sanofi higher dose flu vaccines preferentially recommended for adults 65+ in CDC Morbidity and Mortality Weekly Report
8/26/2022
The Centers for Disease Control and Prevention (CDC) has published the updated Advisory Committee on Immunization Practices (ACIP) guidance granting preferential recommendation for specific flu vaccines in people age 65+.
-
CDC director Dr. Rochelle Walensky announced plans to launch a “reset” of the agency amid criticism over its handling of the COVID-19 pandemic and other public health threats.
-
With more than 6,600 cases of monkeypox in the United States, the Biden administration declared the viral outbreak a public health emergency as cases continue to rise across the nation.
-
Experts from U.S. health regulatory agencies have announced plans to conduct a clinical trial to assess the safety and efficacy of TPOXX (tecovirimat) as an antiviral for monkeypox.
-
The announcement signals that the WHO now views the outbreak as significant enough that a coordinated global response is necessary to control it.
-
COVID-19 Update: BA.4 and BA.5 Dominate, Long COVID Effects Continue, CDC Considers Novavax
7/19/2022
As the BA.4/BA.5 Omicron subvariants spread, researchers continue to develop COVID-19 therapies and approaches for preventing or treating the disease. For that and more, continue reading. -
Quest Diagnostics Partners with CDC to Extend $0 Out-of-pocket COVID-19 Diagnostic Testing to Underserved Communities
7/7/2022
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced it is now a participating partner in the Centers for Disease Control and Prevention's (CDC) Increasing Community Access to Testing (ICATT) for COVID-19 program, which is designed to support free COVID-19 laboratory testing for patients in U.S. communities that have been disproportionately affected by the pandemic.
-
Findings from a study support the claim that the risk of developing a serious issue, such as respiratory or cardiac issues, is much more probable in the first 30 days following infection from COVID-19.
-
Even though the COVID-19 pandemic appears to be under control, it's clear that it's not over, with the rise of more subvariants. Read on for more details.
-
Thursday, a committee of advisors for the CDC voted unanimously for children and teens, ages six to 17 to receive Moderna's COVID-19 vaccine.
-
Although COVID-19 appears to be on the run in the U.S., there is still a threat of resurgence. Here’s a look at some of the most recent COVID-19 stories and research.
-
UPDATE: In Unanimous Vote, FDA Advisory Committee Recommends Moderna's COVID Vaccine for Kids 6-17
6/14/2022
In a unanimous vote, a panel of FDA advisors voted to recommend the approval of Moderna's COVID-19 vaccine for children between the ages of six and 17 years old. -
New Quest Diagnostics Health Trends® Study, in Collaboration with CDC, Shows Less Than Half of Pregnant People Screened for Hepatitis C
6/13/2022
A new Health Trends® study from Quest Diagnostics developed in collaboration with the CDC found that the rate of hepatitis C antibody screening increased 145% in pregnant people during the decade-long study period ending June 2021.
-
On Tuesday, the FDA's Vaccines and Related Biological Products Advisory Committee voted 21-0 with one abstention to recommend authorization of Novavax’s COVID-19 vaccine.
-
CDC Study Finds Shift in Vision Impairment Trends Among Adults with Diabetes
6/4/2022
A Centers for Disease Control and Prevention study provides new insights into vision impairment prevalence over the last 20 years.
-
Nutriband Supports Update to CDC Opioid Prescribing Guidelines
6/3/2022
New proposed guidelines reiterate need for abuse deterrent technologies and call for enabling clinicians to provide comprehensive pain management including appropriate use of opioid medications.
-
Concerns are mounting for people that have been given Pfizer’s Paxlovid treatment regimen after contracting COVID-19, only to become positive for the infection once again.
-
Sunday night, U.S. health authorities announced that they may have found the third documented case of monkeypox in a patient in South Florida.